Video
Author(s):
Edward A. Stadtmauer, MD, section chief of Hematologic Malignancies, Abramson Cancer Center, University of Pennsylvania, discusses the current challenges with multiple myeloma.
The biggest challenge with multiple myeloma is understanding which combinations or sequences to use with these field-changing agents, explains Stadtmauer.
Ongoing trials are helping oncologists understand more about when and how long to treat patients with these agents. Stadtmauer says he is hopeful about the outcome for patients with multiple myeloma.